Liver Disease Clinical Trials in Illinois

64 recruiting studies across 1 city

Browse by City

All Trials in Illinois

Phase

Trial	Phase	Sponsor	Dist.
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial	Phase 3	NRG Oncology	2 mi
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors	Phase 2	SWOG Cancer Research Network	2 mi
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH	Phase 3	89bio, Inc.	2 mi
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH	Phase 3	Akero Therapeutics, Inc	2 mi
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)	Phase 3	89bio, Inc.	2 mi
Therasphere® and Systemic Therapy for Patients With Hepatocellular Carcinoma That is High-risk	Phase 2	Northwestern University	2 mi
Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs	—	European Foundation for Study of Chronic Liver Failure	2 mi
The Myelin Disorders Biorepository Project	—	Children's Hospital of Philadelphia	2 mi
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)	N/A	Perspectum	2 mi
Functional Assessment in Liver Transplantation	—	University of California, San Francisco	2 mi
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)	Phase 2	Deciphera Pharmaceuticals, LLC	2 mi
TReatment for ImmUne Mediated PathopHysiology	Phase 2	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	2 mi
A Study to Check Liver Health in Boys With XLMTM, a Serious Genetic Muscle Condition	—	Astellas Gene Therapies	2 mi
IMARA for Black Male Caregivers and Girls Empowerment (IMAGE)	N/A	University of Illinois at Chicago	2 mi
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)	Phase 3	Bausch Health Americas, Inc.	2 mi
A Prospective Database of Infants With Cholestasis	—	Arbor Research Collaborative for Health	2 mi
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis	Phase 2	Mirum Pharmaceuticals, Inc.	2 mi
PiMZ Longitudinal Cohort (PiMZ Logic)	—	Columbia University	2 mi
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis	Phase 3	Gilead Sciences	2 mi
Primary Sclerosing Cholangitis in Children	—	Arbor Research Collaborative for Health	2 mi
Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation	—	University of Alberta	2 mi
A Trial of Post-Discharge Transitional Care for Patients With Chronic Liver Disease	N/A	Indiana University	2 mi
MAsS Scan as a Predictor of Morbidity and Mortality in Patients With Liver Disease	—	University of Chicago	2 mi
An Open-label Study to Investigate ECUR-506 in Male Babies Less Than 9 Months of Age With Neonatal Onset OTC Deficiency	Phase 1/2	iECURE, Inc.	2 mi
Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIV	Phase 1/2	National Institute of Allergy and Infectious Diseases (NIAID)	2 mi
Changes in Glucose Tolerance in Patients With Cirrhosis Peri-Liver Transplant	—	University of Chicago	2 mi
The Microbiota Augmentation to Reestablish Commensal Organisms (MARCO) Trial	Phase 1	University of Chicago	2 mi
Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease	Phase 2	Justin Ryder	2 mi
Proteogenomic Monitoring and Assessment of Liver Transplant Recipients	—	Northwestern University	2 mi
Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors	N/A	Johns Hopkins University	2 mi
Genetic Collection Protocol	—	Arbor Research Collaborative for Health	2 mi
A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease (IFALD).	Phase 2	NorthSea Therapeutics B.V.	2 mi
Technology Enabled Strategies to Promote Treatment Adherence in Liver Transplant	N/A	University of Pennsylvania	2 mi
HCV Tappt Adherence Study	N/A	University of Illinois at Chicago	2 mi
Longitudinal Study of the Porphyrias	—	The American Porphyrias Expert Collaborative	2 mi
The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing	—	University of Chicago	2 mi
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)	—	HistoSonics, Inc.	2 mi
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry	—	Massive Bio, Inc.	2 mi
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years	Phase 4	Guerbet	2 mi
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)	Phase 1	AbbVie	2 mi
Colorectal Metastasis to Liver Extraction With Auxiliary Transplant and Delayed Resection	—	Northwestern University	2 mi
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors	Phase 1/2	Tango Therapeutics, Inc.	2 mi
The Dragon PLC Trial (DRAGON-PLC)	N/A	Maastricht University	2 mi
Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment	—	Fresenius Kabi	2 mi
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma	Phase 1	Alnylam Pharmaceuticals	2 mi
National Liver Cancer Screening Trial	Phase 4	University of Texas Southwestern Medical Center	2 mi
A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC)	Phase 2/3	AbbVie	2 mi
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer	Phase 2	AstraZeneca	2 mi
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)	Phase 1/2	Bristol-Myers Squibb	2 mi
Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors	Phase 1	Exelixis	2 mi
Optimizing Y90 Therapy for Radiation Lobectomy	—	Northwestern University	2 mi
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors	Phase 1/2	DualityBio Inc.	2 mi
Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer	Phase 2	Academic and Community Cancer Research United	2 mi
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial	Phase 3	ECOG-ACRIN Cancer Research Group	2 mi
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors	Phase 1/2	Children's Oncology Group	2 mi
A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis	Phase 2	Genentech, Inc.	2 mi
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma	Phase 3	AstraZeneca	2 mi
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy	Phase 3	Pierre Fabre Medicament	2 mi
A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02)	Phase 2	Daiichi Sankyo	12 mi
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis	Phase 3	Boehringer Ingelheim	21 mi
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis	Phase 3	Boehringer Ingelheim	21 mi
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer	Phase 2	AstraZeneca	27 mi
Integrated Cancer Repository for Cancer Research	—	University of Nebraska	37 mi
A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors	Phase 1	BeOne Medicines	41 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.